|
Abisax 20 mg
tbl (blis.Al/Al) 1x30 ks
|
|
HLR06AX29 - Bilastín
|
TBL |
Glenmark Pharmaceuticals s.r.o. (CZE) |
GLENMARK PHARMACEUTICALS SK, s.r.o. (SVK)
|
4283E |
9/2024 |
Áno
|
zobraziť
|
|
Abisax 20 mg
tbl (blis.Al/Al) 1x50 ks
|
|
HLR06AX29 - Bilastín
|
TBL |
Glenmark Pharmaceuticals s.r.o. (CZE) |
GLENMARK PHARMACEUTICALS SK, s.r.o. (SVK)
|
4285E |
9/2024 |
Áno
|
zobraziť
|
|
ATARALGIN
tbl 325 mg/130 mg/70 mg (blis.PVC/Al) 1x20 ks
|
|
HLN02BE71 - Paracetamol, kombinácie s psycholeptikami
|
TBL |
Glenmark Pharmaceuticals s.r.o. (CZE) |
GLENMARK PHARMACEUTICALS SK, s.r.o. (SVK)
|
56579 |
- |
Nie
|
zobraziť
|
|
ATARALGIN
tbl 325 mg/130 mg/70 mg (blis.PVC/Al) 1x50 ks
|
|
HLN02BE71 - Paracetamol, kombinácie s psycholeptikami
|
TBL |
Glenmark Pharmaceuticals s.r.o. (CZE) |
GLENMARK PHARMACEUTICALS SK, s.r.o. (SVK)
|
8200A |
1/2014 |
Nie
|
zobraziť
|
|
Deferasirox Glenmark 180 mg
tbl flm (blis.Al/PVC/PVDC) 1x30 ks
|
|
HLV03AC03 - Deferasirox
|
TBL FLM |
Glenmark Pharmaceuticals s.r.o. (CZE) |
-
|
8993D |
4/2022 |
Nie
|
zobraziť
|
|
Deferasirox Glenmark 360 mg
tbl flm (blis.Al/PVC/PVDC) 1x30 ks
|
|
HLV03AC03 - Deferasirox
|
TBL FLM |
Glenmark Pharmaceuticals s.r.o. (CZE) |
GLENMARK PHARMACEUTICALS SK, s.r.o. (SVK)
|
8997D |
4/2022 |
Áno
|
zobraziť
|
|
Dimethyl fumarate Glenmark 120 mg
cps end (blis.PVC/PVDC/Al) 1x14 ks
|
|
HLL04AX07 - Dimetyl-fumarát
|
CPS END |
Glenmark Pharmaceuticals s.r.o. (CZE) |
GLENMARK PHARMACEUTICALS SK, s.r.o. (SVK)
|
4511E |
6/2024 |
Áno
|
zobraziť
|
|
Dimethyl fumarate Glenmark 240 mg
cps end (blis.PVC/PVDC/Al) 1x56 ks
|
|
HLL04AX07 - Dimetyl-fumarát
|
CPS END |
Glenmark Pharmaceuticals s.r.o. (CZE) |
GLENMARK PHARMACEUTICALS SK, s.r.o. (SVK)
|
4512E |
6/2024 |
Áno
|
zobraziť
|
|
Dimexol 200 mg
tbl 1x30 ks (mimoriadny dovoz-výnimka)
|
|
HL - Humánne lieky
|
TBL |
- |
GLENMARK PHARMACEUTICALS SK, s.r.o. (SVK)
|
MD867 |
6/2024 |
Nie
|
zobraziť
|
|
Ezetimibe Glenmark 10 mg tablety
tbl (blis.PVC/Aclar/Al) 1x98 ks
|
|
HLC10AX09 - Ezetimib
|
TBL |
Glenmark Pharmaceuticals s.r.o. (CZE) |
-
|
7139B |
4/2018 |
Nie
|
zobraziť
|
|
Gabapentin Glenmark 100 mg
cps dur (blis.PVC/PVDC/Al) 1x100 ks
|
|
HLN02BF01 - Gabapentín
|
CPS DUR |
Glenmark Pharmaceuticals s.r.o. (CZE) |
GLENMARK PHARMACEUTICALS SK, s.r.o. (SVK)
|
7620D |
10/2021 |
Áno
|
zobraziť
|
|
Gabapentin Glenmark 300 mg
cps dur (blis.PVC/PVDC/Al) 1x200 ks
|
|
HLN02BF01 - Gabapentín
|
CPS DUR |
Glenmark Pharmaceuticals s.r.o. (CZE) |
GLENMARK PHARMACEUTICALS SK, s.r.o. (SVK)
|
7643D |
10/2021 |
Áno
|
zobraziť
|
|
Gabapentin Glenmark 300 mg
cps dur (blis.PVC/PVDC/Al) 1x50 ks
|
|
HLN02BF01 - Gabapentín
|
CPS DUR |
Glenmark Pharmaceuticals s.r.o. (CZE) |
GLENMARK PHARMACEUTICALS SK, s.r.o. (SVK)
|
7636D |
10/2021 |
Áno
|
zobraziť
|
|
Gabapentin Glenmark 400 mg
cps dur (blis.PVC/PVDC/Al) 1x200 ks
|
|
HLN02BF01 - Gabapentín
|
CPS DUR |
Glenmark Pharmaceuticals s.r.o. (CZE) |
GLENMARK PHARMACEUTICALS SK, s.r.o. (SVK)
|
7662D |
10/2021 |
Áno
|
zobraziť
|
|
Gabapentin Glenmark 400 mg
cps dur (blis.PVC/PVDC/Al) 1x50 ks
|
|
HLN02BF01 - Gabapentín
|
CPS DUR |
Glenmark Pharmaceuticals s.r.o. (CZE) |
GLENMARK PHARMACEUTICALS SK, s.r.o. (SVK)
|
7655D |
10/2021 |
Áno
|
zobraziť
|
|
Gabapentin Glenmark 600 mg
tbl flm (blis.PVC/PVDC/Al) 1x200 ks
|
|
HLN03AX12 - Gabapentín (zrušená na WHO 2023, nahradená skupinou N02BF01)
|
TBL FLM |
Glenmark Pharmaceuticals s.r.o. (CZE) |
GLENMARK PHARMACEUTICALS SK, s.r.o. (SVK)
|
8246D |
2/2022 |
Áno
|
zobraziť
|
|
Gabapentin Glenmark 600 mg
tbl flm (blis.PVC/PVDC/Al) 1x50 ks
|
|
HLN03AX12 - Gabapentín (zrušená na WHO 2023, nahradená skupinou N02BF01)
|
TBL FLM |
Glenmark Pharmaceuticals s.r.o. (CZE) |
GLENMARK PHARMACEUTICALS SK, s.r.o. (SVK)
|
8239D |
2/2022 |
Áno
|
zobraziť
|
|
Glezisim 10 mg/20 mg tablety
tbl (blis.PVC/Al/OPA/Al) 1x28 ks
|
|
HLC10BA02 - Simvastatín a ezetimib
|
TBL |
Glenmark Pharmaceuticals s.r.o. (CZE) |
GLENMARK PHARMACEUTICALS SK, s.r.o. (SVK)
|
8990C |
5/2019 |
Áno
|
zobraziť
|
|
Glezisim 10 mg/20 mg tablety
tbl (blis.PVC/Al/OPA/Al) 1x98 ks
|
|
HLC10BA02 - Simvastatín a ezetimib
|
TBL |
Glenmark Pharmaceuticals s.r.o. (CZE) |
GLENMARK PHARMACEUTICALS SK, s.r.o. (SVK)
|
8997C |
5/2019 |
Áno
|
zobraziť
|
|
Glezisim 10 mg/40 mg tablety
tbl (blis.PVC/Al/OPA/Al) 1x28 ks
|
|
HLC10BA02 - Simvastatín a ezetimib
|
TBL |
Glenmark Pharmaceuticals s.r.o. (CZE) |
GLENMARK PHARMACEUTICALS SK, s.r.o. (SVK)
|
9011C |
5/2019 |
Áno
|
zobraziť
|
|
Glezisim 10 mg/40 mg tablety
tbl (blis.PVC/Al/OPA/Al) 1x98 ks
|
|
HLC10BA02 - Simvastatín a ezetimib
|
TBL |
Glenmark Pharmaceuticals s.r.o. (CZE) |
GLENMARK PHARMACEUTICALS SK, s.r.o. (SVK)
|
9018C |
5/2019 |
Áno
|
zobraziť
|
|
Rivaxa 15 mg
tbl flm (blis.PVC/PVDC/Al) 1x28 ks
|
|
HLB01AF01 - Rivaroxabán
|
TBL FLM |
Glenmark Pharmaceuticals s.r.o. (CZE) |
GLENMARK PHARMACEUTICALS SK, s.r.o. (SVK)
|
6750D |
10/2021 |
Áno
|
zobraziť
|
|
Rivaxa 15 mg
tbl flm (blis.PVC/PVDC/Al) 1x42 ks
|
|
HLB01AF01 - Rivaroxabán
|
TBL FLM |
Glenmark Pharmaceuticals s.r.o. (CZE) |
GLENMARK PHARMACEUTICALS SK, s.r.o. (SVK)
|
6752D |
10/2021 |
Áno
|
zobraziť
|
|
Rivaxa 15 mg
tbl flm (blis.PVC/PVDC/Al) 1x98 ks
|
|
HLB01AF01 - Rivaroxabán
|
TBL FLM |
Glenmark Pharmaceuticals s.r.o. (CZE) |
GLENMARK PHARMACEUTICALS SK, s.r.o. (SVK)
|
6754D |
10/2021 |
Áno
|
zobraziť
|
|
Rivaxa 20 mg
tbl flm (blis.PVC/PVDC/Al) 1x28 ks
|
|
HLB01AF01 - Rivaroxabán
|
TBL FLM |
Glenmark Pharmaceuticals s.r.o. (CZE) |
GLENMARK PHARMACEUTICALS SK, s.r.o. (SVK)
|
6757D |
10/2021 |
Áno
|
zobraziť
|
|
Rivaxa 20 mg
tbl flm (blis.PVC/PVDC/Al) 1x98 ks
|
|
HLB01AF01 - Rivaroxabán
|
TBL FLM |
Glenmark Pharmaceuticals s.r.o. (CZE) |
GLENMARK PHARMACEUTICALS SK, s.r.o. (SVK)
|
6760D |
10/2021 |
Áno
|
zobraziť
|
|
Ryaltris 25/600 mikrogramov/dávka
aer nau 240 dávok (fľ.PE s dávkovačom) 1x30 ml
|
|
HLR01AD59 - Mometazón, kombinácie
|
AER NAU |
Glenmark Pharmaceuticals s.r.o. (CZE) |
GLENMARK PHARMACEUTICALS SK, s.r.o. (SVK)
|
7716D |
9/2023 |
Áno
|
zobraziť
|
|
Sunitinib Glenmark 12,5 mg
cps dur (fľ.HDPE) 1x30 ks
|
|
HLL01EX01 - Sunitinib
|
CPS DUR |
Glenmark Pharmaceuticals s.r.o. (CZE) |
GLENMARK PHARMACEUTICALS SK, s.r.o. (SVK)
|
7971D |
2/2022 |
Áno
|
zobraziť
|
|
Sunitinib Glenmark 25 mg
cps dur (fľ.HDPE) 1x30 ks
|
|
HLL01EX01 - Sunitinib
|
CPS DUR |
Glenmark Pharmaceuticals s.r.o. (CZE) |
GLENMARK PHARMACEUTICALS SK, s.r.o. (SVK)
|
7973D |
2/2022 |
Áno
|
zobraziť
|
|
Sunitinib Glenmark 50 mg
cps dur (fľ.HDPE) 1x30 ks
|
|
HLL01EX01 - Sunitinib
|
CPS DUR |
Glenmark Pharmaceuticals s.r.o. (CZE) |
GLENMARK PHARMACEUTICALS SK, s.r.o. (SVK)
|
7977D |
2/2022 |
Áno
|
zobraziť
|
|
Teriflunomide Glenmark 14 mg
tbl flm (blis.Al/Al-jednotl.bal.) 28x1 ks
|
|
HLL04AK02 - Teriflunomid
|
TBL FLM |
Glenmark Pharmaceuticals s.r.o. (CZE) |
GLENMARK PHARMACEUTICALS SK, s.r.o. (SVK)
|
4719E |
10/2024 |
Áno
|
zobraziť
|
